Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

Press releases published on June 22, 2026

2 hours ago

Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

Indeterminate GlobeNewswire

2 hours ago

Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

Indeterminate GlobeNewswire

2 hours ago

Pioneering screening test offers potential to find more aggressive prostate cancers

Indeterminate GlobeNewswire

3 hours ago

20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month

Indeterminate GlobeNewswire

3 hours ago

MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval

Indeterminate GlobeNewswire

3 hours ago

Elevar Therapeutics Announces First Patients Dosed in Phase 2 Study of Lirafugratinib Among Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

Indeterminate GlobeNewswire

3 hours ago

Flyte Partners with GSE Worldwide and PGA TOUR Professional Emiliano Grillo, Debuted at the 2026 U.S. Open

Indeterminate GlobeNewswire

3 hours ago

IMUNON to Present at the Life Sciences Investor Forum on June 25th

Indeterminate GlobeNewswire

3 hours ago

Dyne Therapeutics Appoints Barry Greene to Board of Directors

Indeterminate GlobeNewswire

3 hours ago

Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales

Indeterminate GlobeNewswire

3 hours ago

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

3 hours ago

Tango Therapeutics Appoints Robert Azelby to Board of Directors

Indeterminate GlobeNewswire

3 hours ago

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention

Indeterminate GlobeNewswire

3 hours ago

MoonLake Immunotherapeutics Announces Proposed Public Offering

Indeterminate GlobeNewswire

3 hours ago

Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast

Indeterminate GlobeNewswire

3 hours ago

uniQure Announces $150 Million Proposed Public Offering

Indeterminate GlobeNewswire

3 hours ago

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Indeterminate GlobeNewswire

4 hours ago

New Long-Term Data Shows Lebrikizumab Sustains Atopic Dermatitis Clearance With Less Frequent Dosing and Advances Findings from Dr. Philip Werschler of Spokane Dermatology Clinic

Indeterminate GlobeNewswire